While the prevalence of celiac disease is estimated to be about 1% in the United States, the number of people who have adopted a gluten-free diet is far greater, as shown by the rapidly expanding gluten-free market. For those people who feel better on a gluten-free diet but have tested negative for celiac disease and […]
Celiac disease, typically thought of as a gastrointestinal disease, has a wide variety of symptoms that can affect other parts of the body including the mind. Many people with celiac disease report having “brain fog”, a form of cognitive impairment can encompass disorientation, problems with staying focused and paying attention, and lapses in short-term memory. […]
The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one that found a link between celiac disease and an absence of H. pylori in the stomach. Another paper, involving three of the same doctors, including Celiac Disease Foundation’s own Medical Advisory Board Member Dr. Peter Green, found another possible explanation.
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.
A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first posted online on April 21, 2014, titled “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome” examined nearly a thousand Italian children […]
Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.
Celiac disease, one of the most common autoimmune diseases in the world today, often goes undiagnosed due to asymptomatic patients and many nonspecific symptoms. To diagnose a patient with celiac disease, a positive intestinal biopsy is typically necessary. But when physicians need to decide on whether or not to order a biopsy, they have many […]
Alternatives to gluten are absolutely vital to those diagnosed with celiac disease as the only treatment available currently is a life-long, strict gluten-free diet. Many doctors and nutritionists recommend foods like amaranth, millet, buckwheat, and quinoa as substitutes for wheat and other grains toxic for celiac patients; however, there have been recent laboratory tests that […]
A recent study published by the American Journal of Epidemiology by several scientists including Dr. Peter H. R. Green, the founder of the Columbia University Celiac Disease Center and a Medical Advisory Board member for the Celiac Disease Foundation, has found a link between a particular bacterial strain typically found in the human gut and […]